Hsien-Yi Chiu (H Y Chiu)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 13

Top Venues

Therapeutic advances in chronic disease

Clinical drug investigation

American journal of clinical dermatology

PloS one

National Taiwan University Hospital Hsin-Chu Branch

National Taiwan University (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

National Taiwan University Hospital Hsin-Chu Branch

Taiwan

Attending Physician :: Department of Dermatology

National Taiwan University Hospital

Taiwan

Resident :: Department of Dermatology

National Taiwan University Hospital

Taiwan

Resident :: Department of Family Medicine

Taipei City Hospital Zhongxing Branch

United States

Resident :: Department of Internal Medicine

Education History

National Taiwan University

Taiwan

PHD :: Institute of Biomedical Engineering

Publications

Yu-Huei Huang, Sung Jen Hung, Chaw-Ning Lee, Nan-Lin Wu, Rosaline Chung-Yee Hui, Tsen-Fang Tsai, Chang-Ming Huang, Hsien-Yi Chiu
Predicting the Time to Relapse Following Withdrawal from Different Biologics in Patients with Psoriasis who Responded to Therapy: A 12-Year Multicenter Cohort Study. American journal of clinical dermatology (2024)
Hsien-Yi Chiu, Joung-Liang Lan, Ying-Ming Chiu
Lifetime risk, life expectancy, loss-of-life expectancy, and lifetime healthcare expenditures for psoriasis in Taiwan: a nationwide cohort followed from 2000 to 2017. Therapeutic advances in chronic disease 14 (2023)
Hsien-Yi Chiu, Joung-Liang Lan, Ying-Ming Chiu
Lifetime risk, life expectancy, loss-of-life expectancy, and lifetime healthcare expenditures for psoriasis in Taiwan: a nationwide cohort followed from 2000 to 2017. Therapeutic advances in chronic disease 14 (2023)
Hsien-Yi Chiu, Yi-Teng Hung, Yu-Huei Huang
Comparative short-term risks of infection and serious infection in patients receiving biologic and small-molecule therapies for psoriasis and psoriatic arthritis: a systemic review and network meta-analysis of randomized controlled trials. Therapeutic advances in chronic disease 14 (2023)
Y T Chen, Hsien-Yi Chiu
Short-term Risks of Major Adverse Cardiovascular Events associated with Janus Kinase Inhibitors in Patients with Atopic Dermatitis: A Systematic Review and Meta-Analysis. Journal of the European Academy of Dermatology and Venereology : JEADV (2023)
Hsien-Yi Chiu, Yi-Teng Hung, Shi-Wei Huang, Yu-Huei Huang
Comparative risk of herpes zoster in patients with psoriatic disease on systemic treatments: a systematic review and network meta-analysis. Therapeutic advances in chronic disease 13 (2022)
Hsien-Yi Chiu, Nien-Feng Chang Liao, Yu Lin, Yu-Huei Huang
Perception of the threat, mental health burden, and healthcare-seeking behavior change among psoriasis patients during the COVID-19 pandemic. PloS one 16 (12) (2021)
Yi-Teng Hung, Yu-Jr Lin, Hsien-Yi Chiu, Yu-Huei Huang
Impact of previous biologic use and body weight on the effectiveness of guselkumab in moderate-to-severe plaque psoriasis: a real-world practice. Therapeutic advances in chronic disease 12 (2021)
Nai-Lun Yeh, Che-Yuan Hsu, Tsen-Fang Tsai, Hsien-Yi Chiu
Gut Microbiome in Psoriasis is Perturbed Differently During Secukinumab and Ustekinumab Therapy and Associated with Response to Treatment. Clinical drug investigation 39 (12) (2020)
Kai-Lung Chen, Hsien-Yi Chiu, Jui-Hsiang Lin, Jian-De Ye, Yi-Hsuan Cho, Ko-Jen Li, Tsen Fang Tsai
Prevalence, clinical features and treatment pattern of patients with concurrent diagnoses of rheumatoid arthritis and psoriatic disease: results of a 14-year retrospective study in a tertiary referral center. Therapeutic advances in chronic disease 10 (2019)
Tzong-Yun Ger, Yu-Huei Huang, Rosaline Chung-Yee Hui, Tsen Fang Tsai, Hsien-Yi Chiu
Effectiveness and safety of secukinumab for psoriasis in real-world practice: analysis of subgroups stratified by prior biologic failure or reimbursement. Therapeutic advances in chronic disease 10 (2019)
Hsien-Yi Chiu, Wei-Lun Chang, Tsen-Fang Tsai, Yi-Wen Tsai, Ming-Neng Shiu
Risk of Psoriasis Following Terbinafine or Itraconazole Treatment for Onychomycosis: A Population-Based Case-Control Comparative Study. Drug safety 41 (3) (2018)
Hsien-Yi Chiu, Wei-Lun Chang, Ming-Neng Shiu, Weng-Foung Huang, Tsen-Fang Tsai
Psoriasis is associated with a greater risk for cardiovascular procedure and surgery in patients with hypertension: A nationwide cohort study. The Journal of dermatology 45 (12) (2018)

Hsien-Yi Chiu.css-eqlu8i{font-size:small;padding-left:4px;} (H Y Chiu)

Publication Activity (10 Years)

Top Topics

Top Venues

Hsien-Yi Chiu (H Y Chiu)